The Impact of Disease Activity Criteria on Extending Injection Intervals in Real-World Patients with Neovascular Age-Related Macular Degeneration

Authors: Bhairavi Bhatia, Sing Yue Sim, Evangelia Chalkiadaki, Georgios Koutsocheras, Luke Nicholson, Senthil Selvam, Sobha Sivaprasad, Bishwanath Pal, Josef Huemer, Pearse A. Keane, Robin Hamilton, Praveen J. Patel, Moorfields Medical Retina Injection Service

Source: Ophthalmology and Therapy, Vol 14, Iss 4, Pp 773-786 (2025)

Subject Terms: Anti-vascular endothelial growth factor (anti-VEGF), Neovascular age-related macular degeneration (nAMD), Optical coherence tomography (OCT), Real-world, Ophthalmology, RE1-994

File Description: electronic resource

Relation: https://doaj.org/toc/2193-8245; https://doaj.org/toc/2193-6528

Access URL: https://doaj.org/article/e6dfba6ab8e7439eaa25615d0023906f

To Treat or Not to Treat? Resolving the Question of Subretinal and Intraretinal Fluid in Age-Related Macular Degeneration: A Narrative Review

Authors: Alexander J. E. Foss, David Almeida, Chui Ming Gemmy Cheung, Yuichiro Ogura, Eduard de Cock, Theo Empeslidis

Source: Ophthalmology and Therapy, Vol 14, Iss 3, Pp 489-514 (2025)

Subject Terms: Anti-vascular endothelial growth factor (anti-VEGF), Intraretinal fluid (IRF), Neovascular age-related macular degeneration (nAMD), Macular atrophy, Prognosis, Sub-retinal fluid (SRF), Ophthalmology, RE1-994

File Description: electronic resource

Relation: https://doaj.org/toc/2193-8245; https://doaj.org/toc/2193-6528

Access URL: https://doaj.org/article/ac710ef514994e879a97498a9ae1995e

Vascular Endothelial Growth Factor C and D Signaling Pathways as Potential Targets for the Treatment of Neovascular Age-Related Macular Degeneration: A Narrative Review

Authors: Ian M. Leitch, Michael Gerometta, David Eichenbaum, Robert P. Finger, Nathan C. Steinle, Megan E. Baldwin

Source: Ophthalmology and Therapy, Vol 13, Iss 7, Pp 1857-1875 (2024)

Subject Terms: Neovascular age-related macular degeneration (nAMD), Anti-vascular endothelial growth factor (VEGF), VEGF-C, VEGF-D, Retinal disease, Biologics, Ophthalmology, RE1-994

File Description: electronic resource

Relation: https://doaj.org/toc/2193-8245; https://doaj.org/toc/2193-6528

Access URL: https://doaj.org/article/d12fa22b9c0e429b8a9d7b36d70b8f8f

Home Optical Coherence Tomography Monitoring for Neovascular Age-Related Macular Degeneration: Transformative Technology or Cool Toy?

Authors: Ethan T. Willis, Judy E. Kim, Eric W. Schneider

Source: Ophthalmology and Therapy, Vol 13, Iss 6, Pp 1407-1416 (2024)

Subject Terms: Neovascular age-related macular degeneration (nAMD), Optical coherence tomography (OCT), Home-based OCT, Anti-VEGF therapy, Telemonitoring, Ophthalmology, RE1-994

File Description: electronic resource

Relation: https://doaj.org/toc/2193-8245; https://doaj.org/toc/2193-6528

Access URL: https://doaj.org/article/985562f3a7ec4fa8bce407a7ddc4e4e4

The first Russian register of patients with neovascular age-related macular degeneration: a real-world clinical study

Authors: V. V. Neroev, O. V. Zaytseva, V. A. Petrakovskaya, M. A. Trifonova, E. I. Ganeeva

Source: Российский офтальмологический журнал, Vol 16, Iss 4, Pp 7-26 (2023)

Subject Terms: neovascular age-related macular degeneration (namd), anti-vegf therapy, anti-vegf drugs, intravitreal angiogenesis inhibitors, intravitreal therapy, angiogenesis inhibitor, register, non-interventional study, Ophthalmology, RE1-994

File Description: electronic resource

Relation: https://roj.igb.ru/jour/article/view/1343; https://doaj.org/toc/2072-0076; https://doaj.org/toc/2587-5760

Access URL: https://doaj.org/article/294ffaa941424e60ab3fed19947e46e3

Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects

Authors: Justus G. Garweg, Claudine A. Blum, René-Pierre Copt, Chiara M. Eandi, Katja Hatz, Christian F. Prünte, Eleonora Seelig, Gábor M. Somfai

Source: Ophthalmology and Therapy, Vol 12, Iss 2, Pp 639-655 (2023)

Subject Terms: Brolucizumab, Diabetic macular edema (DME), Intraocular inflammation (IOI), Neovascular age-related macular degeneration (nAMD), Retinal vascular occlusion, Retinal vasculitis, Ophthalmology, RE1-994

File Description: electronic resource

Relation: https://doaj.org/toc/2193-8245; https://doaj.org/toc/2193-6528

Access URL: https://doaj.org/article/4cee70aabcf3434a960a2f9ca42ceb75

Diagnosis, Treatment and Prevention of Age-Related Macular Degeneration

Contributors: Kodjikian, Laurent

Subject Terms: aflibercept monotherapy, polypoidal choroidal vasculopathy, neovascular age-related macular degeneration, good baseline visual acuity, ForeseeHome AMD Monitoring System®, AREDS2-HOME study, age-related macular degeneration, exudation, optical coherence tomography angiography, anti-vascular endothelial growth factor, brolucizumab, epithelial tear, optical coherence tomography, Sorsby’s fundus dystrophy, Sorsby, hereditary retinal dystrophy, choroidal neovascularisation, macular neovascularization, anti-VEGF treatment, long-term FU, treatment outcome, emerging treatment, neovascular age-related macular degeneration (nAMD), Vascular Endothelial Growth Factor (VEGF), cataract surgery, clinical trials, real-world evidence, AMD, oct-angiography, fellow eye, choriocapillaris, quiescent macular neovascularization, ranibizumab, aflibercept, anti-VEGF, visual acuity, reading acuity, disease activity, treatment change, treat and extend, switch therapy, retina, choroidal neovascularization, angiogenesis, meteorin, therapeutic innovation, prevention, nutrients, lifestyle, treatment-naive, anti–vascular endothelial growth factor, cardiovascular risk factors, arterial hypertension, macula-off rhegmatogenous detachment, superficial perifoveal capillary plexus, retinal deep perifoveal capillary plexus, identification, risk, Delphi, STARS®, food supplement, bevacizumab, meta-analysis, meta-regression, age-related macular degeneration (AMD), comparative therapies, effectiveness, intravitreal anti-vascular endothelial growth factor, treat-and-extend, pro re nata regimen, Medicine and Nursing

File Description: image/jpeg

Access URL: https://directory.doabooks.org/handle/20.500.12854/81005
https://mdpi.com/books/pdfview/book/5347

Long-term impact of delayed follow-up due to COVID-19 lockdown on patients with neovascular age-related macular degeneration

Authors: Stephan Szegedi, Christian Ebner, Kata Miháltz, Tobias Wachter, Pia Veronika Vécsei-Marlovits

Source: BMC Ophthalmology, Vol 22, Iss 1, Pp 1-7 (2022)

Subject Terms: Neovascular age-related macular degeneration (nAMD), Coronavirus disease 2019 (COVID-19), Anti-vascular endothelial growth factor (anti-VEGF), Ophthalmology, RE1-994

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2415

Access URL: https://doaj.org/article/f23a6e1f49364bc9ac8dd390f7ef341c

First Year Real Life Experience With Intravitreal Brolucizumab for Treatment of Refractory Neovascular Age-Related Macular Degeneration

Authors: Alaa Din Abdin, Wissam Aljundi, Khalil El Jawhari, Shady Suffo, Isabel Weinstein, Berthold Seitz

Source: Frontiers in Pharmacology, Vol 13 (2022)

Subject Terms: neovascular age-related macular degeneration (nAMD), intraocular inflammation, intravitreal brolucizumab, switching therapy, refractory macular edema, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2022.860784/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/56554276557a46ac8569343fb10182ff

Anatomical and functional responses to single brolucizumab injection in neovascular age-related macular degeneration patients not responding to antiangiogenics: a case series

Authors: Silvio Zuccarini, Fabrizio Puce, Alessandro Crisà

Source: Drug Target Insights, Vol 16, Iss 1 (2022)

Subject Terms: Anti-VEGF, Brolucizumab, Case series, Neovascular age-related macular degeneration (nAMD), Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://journals.aboutscience.eu/index.php/dti/article/view/2343; https://doaj.org/toc/1177-3928

Access URL: https://doaj.org/article/8ff79ad733bd4203af62297da929a123

Dihydroartemisinin Inhibits Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular AMD

Authors: Xun Li, Sheng Gao, Yun Zhang, Mei Xin, Cheng Zuo, Naihong Yan, Qingjie Xia, Meixia Zhang

Source: Frontiers in Pharmacology, Vol 13 (2022)

Subject Terms: dihydroartemisinin (DHA), neovascular age-related macular degeneration (nAMD), choroidal neovascularization, NF-κB signaling pathway, antiangiogenic efficacy, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2022.838263/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/fc7eceb39fa54ae18f6aef5269c62c03

Gene-Based Therapeutics for Acquired Retinal Disease: Opportunities and Progress

Authors: Tien-En Tan, Beau James Fenner, Veluchamy Amutha Barathi, Sai Bo Bo Tun, Yeo Sia Wey, Andrew Shih Hsiang Tsai, Xinyi Su, Shu Yen Lee, Chui Ming Gemmy Cheung, Tien Yin Wong, Jodhbir Singh Mehta, Kelvin Yi Chong Teo

Source: Frontiers in Genetics, Vol 12 (2021)

Subject Terms: gene therapy, genome editing, ocular biofactory, neovascular age related macular degeneration (nAMD), geographic atrophy (GA), diabetic retinopathy (DR), Genetics, QH426-470

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fgene.2021.795010/full; https://doaj.org/toc/1664-8021

Access URL: https://doaj.org/article/b5f0b2fc772349fc945891ecfe115e98

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.